Home Pilots Variantyx nabs $41.1M for tech-backed genomic analysis Pilots Variantyx nabs $41.1M for tech-backed genomic analysis By - February 14, 2022 81 0 Facebook Twitter Pinterest WhatsApp The company plans to use the funds to focus on the oncology space. RELATED ARTICLESMORE FROM AUTHOR Pilots Former Ripple exec Greg Kidd buys Know Labs with Bitcoin Pilots RadNet acquires See-Mode Technologies for access, revenue growth Pilots FDA launches AI tool for its employees LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Healthee secures $50M in an oversubscribed Series B round Pilots - April 24, 2025 0 Smartphone-based COVID-19 detection test from Australia shows high accuracy Pilots - March 22, 2022 0 BioIntelliSense acquires AlertWatch to expand its patient monitoring products Pilots - October 18, 2022 0 Glooko acquires fellow diabetes management company DIABNEXT and more digital health briefs Pilots - March 17, 2022 0 VMocion secures $3M for virtual motion technology Pilots - January 4, 2024 0 POPULAR CATEGORIESPilots2369Applications835Testing285Collaborations15GitHub3
